BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 28751823)

  • 1. Global Autorecognition and Activation of Complement by Mannan-Binding Lectin in a Mouse Model of Type 1 Diabetes.
    Axelgaard E; Østergaard JA; Haxha S; Thiel S; Hansen TK
    Mediators Inflamm; 2017; 2017():9403754. PubMed ID: 28751823
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diabetes Is Associated with Increased Autoreactivity of Mannan-Binding Lectin.
    Axelgaard E; Østergaard JA; Thiel S; Hansen TK
    J Diabetes Res; 2017; 2017():6368780. PubMed ID: 28349070
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased Autoreactivity of the Complement-Activating Molecule Mannan-Binding Lectin in a Type 1 Diabetes Model.
    Østergaard JA; Ruseva MM; Malik TH; Hoffmann-Petersen IT; Pickering MC; Thiel S; Hansen TK
    J Diabetes Res; 2016; 2016():1825738. PubMed ID: 26977416
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mannan-binding lectin in diabetic kidney disease: the impact of mouse genetics in a type 1 diabetes model.
    Østergaard JA; Bjerre M; RamachandraRao SP; Sharma K; Nyengaard JR; Hansen TK; Thiel S; Flyvbjerg A
    Exp Diabetes Res; 2012; 2012():678381. PubMed ID: 22645604
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diabetes-induced changes in mannan-binding lectin levels and complement activation in a mouse model of type 1 diabetes.
    Ostergaard JA; Bjerre M; Dagnaes-Hansen F; Hansen TK; Thiel S; Flyvbjerg A
    Scand J Immunol; 2013 Mar; 77(3):187-94. PubMed ID: 23350935
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mannose-binding lectin deficiency attenuates renal changes in a streptozotocin-induced model of type 1 diabetes in mice.
    Østergaard J; Thiel S; Gadjeva M; Hansen TK; Rasch R; Flyvbjerg A
    Diabetologia; 2007 Jul; 50(7):1541-9. PubMed ID: 17473913
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mannan-binding lectin recognizes structures on ischaemic reperfused mouse kidneys and is implicated in tissue injury.
    Møller-Kristensen M; Wang W; Ruseva M; Thiel S; Nielsen S; Takahashi K; Shi L; Ezekowitz A; Jensenius JC; Gadjeva M
    Scand J Immunol; 2005 May; 61(5):426-34. PubMed ID: 15882434
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Relationship between activation of mannan-binding lectin complement and NF-kappaB in diabetic nephropathy].
    Yang YX; Huang SM; Yan XY; Wu WH
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2011 Jul; 42(4):490-3. PubMed ID: 21866632
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mannose-binding lectin (MBL) and vascular complications in diabetes.
    Hansen TK
    Horm Metab Res; 2005 Apr; 37 Suppl 1():95-8. PubMed ID: 15918118
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Simultaneous pancreas-kidney transplantation in patients with type 1 diabetes reverses elevated MBL levels in association with MBL2 genotype and VEGF expression.
    Bijkerk R; van der Pol P; Khairoun M; van Gijlswijk-Jansen DJ; Lievers E; de Vries AP; de Koning EJ; de Fijter HW; Roelen DL; Vossen RH; van Zonneveld AJ; van Kooten C; Reinders ME
    Diabetologia; 2016 Apr; 59(4):853-8. PubMed ID: 26768002
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mannose-binding lectin binds IgM to activate the lectin complement pathway in vitro and in vivo.
    McMullen ME; Hart ML; Walsh MC; Buras J; Takahashi K; Stahl GL
    Immunobiology; 2006; 211(10):759-66. PubMed ID: 17113913
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased all-cause mortality in patients with type 1 diabetes and high-expression mannan-binding lectin genotypes: a 12-year follow-up study.
    Østergaard JA; Thiel S; Lajer M; Steffensen R; Parving HH; Flyvbjerg A; Rossing P; Tarnow L; Hansen TK
    Diabetes Care; 2015 Oct; 38(10):1898-903. PubMed ID: 26180106
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased susceptibility of complement factor B/C2 double knockout mice and mannan-binding lectin knockout mice to systemic infection with Candida albicans.
    Held K; Thiel S; Loos M; Petry F
    Mol Immunol; 2008 Sep; 45(15):3934-41. PubMed ID: 18672286
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mannan-binding lectin deficiency results in unusual antibody production and excessive experimental colitis in response to mannose-expressing mild gut pathogens.
    Müller S; Schaffer T; Flogerzi B; Seibold-Schmid B; Schnider J; Takahashi K; Darfeuille-Michaud A; Vazeille E; Schoepfer AM; Seibold F
    Gut; 2010 Nov; 59(11):1493-500. PubMed ID: 20682699
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Investigations on the involvement of the lectin pathway of complement activation in anaphylaxis.
    Windbichler M; Echtenacher B; Takahashi K; Ezekowitz RA; Schwaeble WJ; Jenseniuis JC; Männel DN
    Int Arch Allergy Immunol; 2006; 141(1):11-23. PubMed ID: 16804320
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oligomerization of Mannan-binding Lectin Dictates Binding Properties and Complement Activation.
    Kjaer TR; Jensen L; Hansen A; Dani R; Jensenius JC; Dobó J; Gál P; Thiel S
    Scand J Immunol; 2016 Jul; 84(1):12-9. PubMed ID: 27104295
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mannose-Binding Lectin Drives Platelet Inflammatory Phenotype and Vascular Damage After Cerebral Ischemia in Mice via IL (Interleukin)-1α.
    Orsini F; Fumagalli S; Császár E; Tóth K; De Blasio D; Zangari R; Lénárt N; Dénes Á; De Simoni MG
    Arterioscler Thromb Vasc Biol; 2018 Nov; 38(11):2678-2690. PubMed ID: 30354247
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibody-mediated activation of the classical pathway of complement may compensate for mannose-binding lectin deficiency.
    Roos A; Garred P; Wildenberg ME; Lynch NJ; Munoz JR; Zuiverloon TC; Bouwman LH; Schlagwein N; Fallaux van den Houten FC; Faber-Krol MC; Madsen HO; Schwaeble WJ; Matsushita M; Fujita T; Daha MR
    Eur J Immunol; 2004 Sep; 34(9):2589-98. PubMed ID: 15307191
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cholesterol Crystals Activate the Lectin Complement Pathway via Ficolin-2 and Mannose-Binding Lectin: Implications for the Progression of Atherosclerosis.
    Pilely K; Rosbjerg A; Genster N; Gal P; Pál G; Halvorsen B; Holm S; Aukrust P; Bakke SS; Sporsheim B; Nervik I; Niyonzima N; Bartels ED; Stahl GL; Mollnes TE; Espevik T; Garred P
    J Immunol; 2016 Jun; 196(12):5064-74. PubMed ID: 27183610
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New insights on the structural/functional properties of recombinant human mannan-binding lectin and its variants.
    Rajagopalan R; Salvi VP; Jensenius JC; Rawal N
    Immunol Lett; 2009 Apr; 123(2):114-24. PubMed ID: 19428558
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.